Evidence map›Paper›PMID 36671271›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications.

Zikria Saleem, Abdul Haseeb, Brian Godman, Narjis Batool, Ummara Altaf, Umar Ahsan, Faiz Ullah Khan, Zia Ul Mustafa, Muhammad Umer Nadeem, Muhammad Junaid Farrukh and 8 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 8 countries.

Zikria SaleemDepartment of Pharmacy Practice, Faculty of Pharmacy, Bahuddin Zakaria University, Multan 60800, Pakistan.ORCID 0000-0003-3202-6347
Abdul HaseebDepartment of Clinical Pharmacy, College of Pharmacy, Umm AL-Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0003-2455-5054
Brian GodmanCentre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates.ORCID 0000-0001-6539-6972
Narjis BatoolAustralian Institute of Health Innovation, Center of Health Systems and Safety Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney 2109, Australia.
Ummara AltafGhurki Trust Teaching Hospital, Lahore 54000, Pakistan.
Umar AhsanDepartment of Infection Prevention and Control, Alnoor Specialist Hospital, Ministry of Health, Makkah 24382, Saudi Arabia.
Faiz Ullah KhanDepartment of Pharmacy Administration and Clinical Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.ORCID 0000-0002-1022-8688
Zia Ul MustafaDiscipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Malaysia.ORCID 0000-0002-8109-4859
Muhammad Umer NadeemPunjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan.
Muhammad Junaid FarrukhFaculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia.
Muhammad MugheeraPunjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan.
Inaam Ur RehmanPunjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan.
Asma Fareed KhanChildren's Hospital and University of Child Health Sciences, Lahore 54000, Pakistan.
Hamid SaeedPunjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan.ORCID 0000-0002-1400-4825
Mohammad Akbar HossainDepartment of Pharmacology and Toxicology, Faculty of Medicine in Al-Qunfudah, Umm Al-Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0001-8990-9875
Mohamed RaafatDepartment of Pharmacology and Toxicology, College of Pharmacy, Umm AL-Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0002-1052-2940
Rozan Mohammad RadwanPharmaceutical Care Department, Alnoor Specialist Hospital, Ministry of Health, Makkah 24382, Saudi Arabia.
Muhammad Shahid IqbalDepartment of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Alkharj 11942, Saudi Arabia.ORCID 0000-0003-0245-5976
University of the Punjab · PKUmm al-Qura University · SAMinistry of Health · SABahauddin Zakariya University · PKMacquarie University · AUPrince Sattam Bin Abdulaziz University · SAUCSI University · MYUniversiti Sains Malaysia · MYUniversity of Health Sciences Lahore · PKUniversity of Strathclyde · GBXi'an Jiaotong University · CN

Funding

Deanship for Research & Innovation, Ministry of Education, Saudi Arabia IFP22UQU4290073DSR133
6 · The paper itself

Abstract

The COVID-19 pandemic has significantly influenced antimicrobial use in hospitals, raising concerns regarding increased antimicrobial resistance (AMR) through their overuse. The objective of this study was to assess patterns of antimicrobial prescribing during the current COVID-19 pandemic among hospitals in Pakistan, including the prevalence of COVID-19. A point prevalence survey (PPS) was performed among 11 different hospitals from November 2020 to January 2021. The study included all hospitalized patients receiving an antibiotic on the day of the PPS. The Global-PPS web-based application was used for data entry and analysis. Out of 1024 hospitalized patients, 662 (64.64%) received antimicrobials. The top three most common indications for antimicrobial use were pneumonia (13.3%), central nervous system infections (10.4%) and gastrointestinal indications (10.4%). Ceftriaxone (26.6%), metronidazole (9.7%) and vancomycin (7.9%) were the top three most commonly prescribed antimicrobials among surveyed patients, with the majority of antibiotics administered empirically (97.9%). Most antimicrobials for surgical prophylaxis were given for more than one day, which is a concern. Overall, a high percentage of antimicrobial use, including broad-spectrums, was seen among the different hospitals in Pakistan during the current COVID-19 pandemic. Multifaceted interventions are needed to enhance rational antimicrobial prescribing including limiting their prescribing post-operatively for surgical prophylaxis.

Indexed as

antimicrobial resistanceantimicrobial stewardship programsantimicrobial utilizationCOVID-19irrational use of antibioticsPakistanpoint prevalence survey

Identifiers

PMID36671271
PMCPMC9854885
OpenAlexW4313402280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.